UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000026113 |
|---|---|
| Receipt number | R000030008 |
| Scientific Title | A questionnaire survey of growth hormone supplemental therapy |
| Date of disclosure of the study information | 2017/02/20 |
| Last modified on | 2020/03/02 12:08:50 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A questionnaire survey of growth hormone supplemental therapy
Acronym
Questionnaire growth hormone therapy
Scientific Title
A questionnaire survey of growth hormone supplemental therapy
Scientific Title:Acronym
Questionnaire growth hormone therapy
Region
| Japan |
Condition
Condition
short stature
Classification by specialty
| Pediatrics |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
I disclose reason for encouter, problem of explanation check and therapy induction for short stature.
I can make use of my experiences there for future developments in therapy for short stature.
Basic objectives2
Others
Basic objectives -Others
Patients and their families enforcing growth hormone replacement therapy now
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Questionnaire collection and analysis
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 3 | years-old | < |
Age-upper limit
| 20 | years-old | > |
Gender
Male and Female
Key inclusion criteria
The person that it was obtained consent for questionary survey among the patients who continued growth hormone replacement therapy in our hospital
Key exclusion criteria
The person that it was not obtained consent for questionary survey
Target sample size
26
Research contact person
Name of lead principal investigator
| 1st name | Yutaka |
| Middle name | |
| Last name | Kikuchi |
Organization
Haga red cross hospital
Division name
department of pediatrics
Zip code
321-4308
Address
Moka city, Daimachi 2461, Tochigi pref.
TEL
0285822195
y.kikuchi@haga.jrc.or.jp
Public contact
Name of contact person
| 1st name | Yutaka |
| Middle name | |
| Last name | Kikuchi |
Organization
Haga red cross hospital
Division name
department of pediatrics
Zip code
321-4308
Address
Moka city, Daimachi 2461, Tochigi pref.
TEL
0285822195
Homepage URL
y.kikuchi@haga.jrc.or.jp
Sponsor or person
Institute
Haga red cross hospital
Institute
Department
Personal name
Funding Source
Organization
Haga red cross hospital
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
haga redcross hospital
Address
Nakago 271, Moka-city, Tochigi-pref.
Tel
0285-82-2195
y.kikuchi@haga.jrc.or.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 02 | Month | 20 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 01 | Month | 13 | Day |
Date of IRB
| 2016 | Year | 02 | Month | 01 | Day |
Anticipated trial start date
| 2017 | Year | 03 | Month | 01 | Day |
Last follow-up date
| 2019 | Year | 08 | Month | 17 | Day |
Date of closure to data entry
Date trial data considered complete
| 2019 | Year | 08 | Month | 17 | Day |
Date analysis concluded
| 2020 | Year | 03 | Month | 01 | Day |
Other
Other related information
There is no special findings.
Management information
Registered date
| 2017 | Year | 02 | Month | 13 | Day |
Last modified on
| 2020 | Year | 03 | Month | 02 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030008
